Stockscreener 앱 받기
11.86
4.28%
-0.53
시장 영업 전:
11.92
0.06
+0.51%
전일 마감가:
$12.39
열려 있는:
$12.4
하루 거래량:
1.28M
Relative Volume:
0.59
시가총액:
$808.75M
수익:
$2.73B
순이익/손실:
$-1.13B
주가수익비율:
-0.7118
EPS:
-16.6622
순현금흐름:
$-83.00M
1주 성능:
+14.92%
1개월 성능:
-0.34%
6개월 성능:
-51.29%
1년 성능:
-60.70%
1일 변동 폭
$11.84
$12.74
1주일 범위
$10.34
$12.74
52주 변동 폭
$9.92
$35.58
Quidelortho Corp Stock (QDEL) Company Profile
명칭
Quidelortho Corp
전화
(858) 552-1100
주소
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corp
|
11.86 | 844.89M | 2.73B | -1.13B | -83.00M | -16.66 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-07 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-05-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-12-10 | 개시 | Jefferies | Hold |
| 2024-09-19 | 재개 | UBS | Neutral |
| 2024-09-05 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2024-03-04 | 다운그레이드 | UBS | Neutral → Sell |
| 2024-02-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-14 | 업그레이드 | UBS | Sell → Neutral |
| 2022-09-19 | 개시 | Citigroup | Neutral |
| 2022-07-20 | 개시 | UBS | Sell |
| 2022-06-17 | 재개 | JP Morgan | Neutral |
| 2022-02-22 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-03-26 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2018-10-23 | 재개 | Raymond James | Strong Buy |
| 2018-03-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | 재확인 | Barclays | Overweight |
| 2018-01-04 | 업그레이드 | CL King | Neutral → Buy |
| 2017-09-19 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | 재확인 | Canaccord Genuity | Hold |
| 2017-02-17 | 개시 | CL King | Neutral |
| 2016-12-16 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | 재확인 | Barclays | Overweight |
| 2016-02-09 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | 재확인 | Canaccord Genuity | Buy |
| 2015-12-14 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | 개시 | Barclays | Overweight |
| 2013-07-31 | 재확인 | Canaccord Genuity | Buy |
| 2011-03-03 | 다운그레이드 | Wedbush | Outperform → Neutral |
모두보기
Quidelortho Corp 주식(QDEL)의 최신 뉴스
QuidelOrtho Corp (QDEL) Stock Down 4.2% -- Now Undervalued? GF S - GuruFocus
How Quidelortho Corp Com (QDEL) Affects Rotational Strategy Timing - Stock Traders Daily
When Blood Compatibility Becomes a Pregnancy Risk – Company Announcement - Financial Times
QuidelOrtho stock (US7476011036): Shares rise after latest market move - AD HOC NEWS
QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences - Yahoo Finance
QuidelOrtho (QDEL) price target decreased by 34.46% to 19.25 - MSN
QuidelOrtho stock (US7476011036): Shares fall after recent after-hours pressure - AD HOC NEWS
QuidelOrtho Corp stock (US7476011036): analysts divided as short interest climbs and sentiment weake - AD HOC NEWS
5 Insightful Analyst Questions From QuidelOrtho’s Q1 Earnings Call - Yahoo Finance
QuidelOrtho Corp (QDEL) Shares Surge 3.0% -- What GF Score of 48 Tells Investors - GuruFocus
QuidelOrtho stock (US7476011036): Q1 loss narrows as shares stay under pressure - AD HOC NEWS
QuidelOrtho stock sinks to 52-week lowhere's why - MSN
QuidelOrtho: A Growing, Stable Business With A Significant Mispricing (NASDAQ:QDEL) - Seeking Alpha
QuidelOrtho (QDEL) Q1 2026 Earnings Transcript - AOL.com
QuidelOrtho (NASDAQ:QDEL) misses Q1 CY2026 revenue estimates - MSN
Deckers, Franklin, Eaton, Coupang, QuidelOrtho Trending Among Analysts - TipRanks
QuidelOrtho Corporation 2026 Q1ResultsEarnings Call Presentation (NASDAQ:QDEL) 2026-05-08 - Seeking Alpha
QuidelOrtho Corp stock (US7476011036): Q1 2026 loss widens as respiratory sales weaken - AD HOC NEWS
Pregnancy Detection Kits Market Analysis Report 2026 - GlobeNewswire Inc.
QuidelOrtho Is Maintained at Neutral by Citigroup - Moomoo
QuidelOrtho (QDEL) reports Q1 loss, tops revenue estimates - MSN
QuidelOrtho price target lowered to $12 from $17 at UBS - TipRanks
QuidelOrtho downgraded to Hold from Buy at Jefferies - TipRanks
UBS Adjusts Price Target on QuidelOrtho to $12 From $17, Maintains Neutral Rating - marketscreener.com
Jefferies Maintains QuidelOrtho(QDEL.US) With Hold Rating, Maintains Target Price $12.5 - Moomoo
Jefferies Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $12.50 From $35 - marketscreener.com
QuidelOrtho reports GAAP net loss of USD 92M in Q1 2026 - Medical Buyer
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL), Contineum Therapeutics, Inc. Class A (CTNM) and Schrodinger (SDGR) - The Globe and Mail
QuidelOrtho (QDEL) Loss Deepens In Q1 As Long Trailing Losses Challenge Bullish Narratives - simplywall.st
QDEL SEC FilingsQuidel 10-K, 10-Q, 8-K Forms - Stock Titan
QuidelOrtho Balances Near-Term Strain With Recovery Plan - TipRanks
QUIDELORTHO Corporation Q1 2026 SEC 10-Q Filing: Financial Results, Risk Factors, and Management Discussion - Minichart
Invesco Ltd. reports 4.6% stake in QuidelOrtho (NASDAQ: QDEL) - Stock Titan
Newtyn Management (NASDAQ: QDEL) reports 4.56M shares, 6.7% holding - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
William Blair Maintains QuidelOrtho(QDEL.US) With Hold Rating, Announces Target Price $11.66 - Moomoo
QuidelOrtho Corporation (NASDAQ:QDEL) Q1 2026 Earnings Call Transcript - Insider Monkey
QuidelOrtho forecasts $2.7B-$2.75B 2026 revenue while targeting $100M-$120M free cash flow amid China pricing uncertainty - MSN
QuidelOrtho : Quarterly Report for Quarter Ending March 29, 2026 (Form 10-Q) - marketscreener.com
QDEL Q1 Deep Dive: Softer Respiratory Demand and China Headwinds Drive Guidance Reset - The Globe and Mail
QuidelOrtho Q1 2026 slides: revenue falls 13%, respiratory weakness pressures margins - Investing.com Nigeria
QuidelOrtho Q1 Earnings Call Highlights - Yahoo Finance
QuidelOrtho Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: QuidelOrtho Q1 2026 results miss expectations - Investing.com UK
QuidelOrtho Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: QuidelOrtho Q1 2026 results miss expectations By Investing.com - Investing.com Nigeria
QuidelOrtho (QDEL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
QuidelOrtho (NASDAQ: QDEL) posts Q1 2026 loss as revenue declines 11% - Stock Titan
Q1 2026 QuidelOrtho Corp Earnings Call Transcript - GuruFocus
Quidelortho Corp (QDEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.22%
1.41%
자본화:
|
볼륨(24시간):